Epigenomics AGEpigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 11.05.2022 / 15:38 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of […]
Author: christophleo
11. May 2022
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Read more
10. May 2022
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AGEpigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 10.05.2022 / 17:39 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of […]
27. April 2022
Epigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AGEpigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung 27.04.2022 / 20:38 Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Stimmrechtsmitteilung 1. Angaben zum Emittenten Name: Epigenomics AG Straße, Hausnr.: Geneststraße 5 PLZ: […]
27. April 2022
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG / Total Voting Rights AnnouncementEpigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 27.04.2022 / 09:58 Total Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Publication […]
26. January 2022
Epigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG26.01.2022 / 10:12 Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Stimmrechtsmitteilung 1. Angaben zum Emittenten Name: Epigenomics AG Straße, Hausnr.: Geneststraße 5 PLZ: 10829 Ort: BerlinDeutschland Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. Grund der Mitteilung Erwerb bzw. […]
21. January 2022
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG21.01.2022 / 11:30 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]